In a few cancers (particularly TCGT), CDKN2C expression was related to multiple immune-related genes, including TMEM173 (an immunostimulator) (Fig. 9B), IL10RB (an immunoinhibitory) (Fig. 9C), and TAPBP (a major histocompatibility complex molecule) (Fig. 9D) in TGCT. This evidence concerns the gene CDKN2C and cancer.